Login
Companies $FEMY
$1.30 +$0.02 (1.56%) After hours
FEMASYS INC logo

FEMASYS INC

femasys.com

What Do They Do?

Sells in-office fertility treatments and diagnostic devices, sperm-preparation products, and non-surgical permanent birth-control systems to gynecologists, fertility specialists, and medical centers.

How Do They Make Money?

Sells medical products to U.S. medical centers and practitioner offices mainly through its direct commercial team, and to international customers through distributors; customers are typically billed when goods ship and pay within 30 to 60 days.

FY2025 revenue

Who Are Their Customers?

U.S. medical centers, including practitioner offices, buy primarily through the company’s direct commercial team; international customers buy through distributors.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2024: 27% from two customers

Do Revenues Turn Into Profits?

No. It lost $18.6M in FY2025.

Operating income, FY2025
−767% of revenue
▲ +1% (Loss) vs FY2024 (−$17.8M, −1092%)
Net income, FY2025
−812% of revenue
▲ +1% (Loss) vs FY2024 (−$18.8M, −1155%)
Free cash flow, FY2025
−838% of revenue
▲ +5% (Loss) vs FY2024 (−$20.2M, −1240%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −45%
vs $729.4K in Q3 FY2025
Net income
▼ −9% (Loss)
vs −$4.2M in Q3 FY2025

FemaSeed reaches commercialization The earlier report described FemaSeed as a product candidate in development; the latest report describes it as cleared and commercially sold, alongside FemSperm kits for in-office sperm preparation.

FemBloc advances beyond development The earlier report described FemBloc as in development; the latest report says it has regulatory approvals in Europe, the UK and New Zealand, with distribution partnerships in select international markets.

Who Do They Compete With?

Competes with Cook Medical, Cooper Surgical, MedGyn Products, Rocket Medical, Dysis Medical, and Guided Therapeutics

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support